Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALMEFENE vs NAPROXEN\SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALMEFENE vs NAPROXEN\SUMATRIPTAN: Safety Overview

Metric NALMEFENE NAPROXEN\SUMATRIPTAN
Total FAERS Reports 197 233
Deaths Reported 77 15
Death Rate 39.1% 6.4%
Hospitalizations 118 14
Average Patient Age 44.2 yrs 47.8 yrs
% Female Patients 39.3% 84.5%
FDA Approval Date Apr 17, 1995 N/A
Manufacturer Purdue Pharma L.P. N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A